LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Smal Cel Lung Cancer

Authors
Category Primary study
ConferenceXXVI AIOM National Congress
Year 2024
This article has no abstract
Epistemonikos ID: 194aa96d0d210cfe7b55d3c62a38f0a0c5f7c148
First added on: Feb 16, 2026